Take statins, drugs that aim to reduce bad cholesterol. A typical trial might give one group of men a statin for, say, ... In healthy men, the NNT for statins is about 50 ...

Statins are lipid-lowering drugs in extremely common use in the UK and ... his risk is now 29% for a coronary event over the next decade because he is taking statins. The NNT is 11 in this case.

They tracked changes to European statin guidance over the past 30 years and found a 600% increase in the number of over 50s eligible for the drugs. In the late 1980s, only the most high-risk patients ...

Sales of the drug to patients with inherited high cholesterol were $126 million in 2024. Lilly, Arrowhead Pharmaceuticals, and Regeneron are all testing so-called siRNA drugs that interfere with ...

No Results. Monday, March 3, 2025 ...

With the average life expectancy at 76 for men and 81 for women in the U.S., drug companies haven't funded such studies in people above 79. There have been many studies involving younger people.

Past studies have suggested that taking cholesterol-lowering statin drugs may lower individuals' risk of developing liver cancer. In a new study of non-statin cholesterol-lowering medications, one ...

Clinical trials comparing cholesterol-lowering drugs to one another are far more likely to yield results favoring the one whose maker paid for the research, scientists said on Monday in the latest ...